Reduction of post-traumatic intracranial hypertension by hypertonic/hyperoncotic saline/dextran and hypertonic mannitol
- PMID: 8587698
- DOI: 10.1227/00006123-199507000-00015
Reduction of post-traumatic intracranial hypertension by hypertonic/hyperoncotic saline/dextran and hypertonic mannitol
Abstract
Cerebral injury is seen in one of three patients with multiple traumas; thus efficient shock treatment is a most important measure against the development of secondary brain damage. Small-volume resuscitation in severe hemorrhagic shock by hypertonic/hyperoncotic saline/dextran has been shown to instantaneously normalize cardiac output and to raise systemic blood pressure. In this study, the fluid regimen was compared with hypertonic mannitol to investigate their therapeutic efficacy in intracranial hypertension. The experiments were performed in rabbits subjected to a focal lesion of the brain to induce acute, vasogenic brain edema. The resulting intracranial hypertension was enhanced in a standard manner by inflation of an epidural balloon until an intracranial pressure (ICP) of 17 mm Hg was obtained. Intravenous administration of either 7.2% saline/10% dextran-60 or of 20% mannitol rapidly decreased the elevated ICP. After the first injection, ICP lowering was maintained longer by the mannitol than by the hypertonic saline/dextran, whereas no differences in duration of ICP lowering were found when the infusions of these solutions were repeated. The systemic blood pressure increased after injection of the saline/dextran solution, but it tended to decrease after injection of the mannitol. Transient increases in plasma osmolality, colloid-osmotic pressure, and plasma-Na+ were more pronounced after administration of the saline/dextran solution than after the administration of the mannitol. No difference in the tissue water content between the traumatized and contralateral hemisphere was observed in the animals receiving mannitol; however, after saline/dextran infusion, the water content was somewhat increased in the exposed hemisphere but decreased in the nonexposed, contralateral hemisphere (decreased to a point even below the corresponding level of animals who received the mannitol). The increase of the cerebral water content of the traumatized hemisphere was associated with a respective increase of the cerebral Na+ content and a (nonsignificant) decrease of the K+ content. The present findings demonstrate that the hypertonic/hyperoncotic saline/dextran was as efficient as the mannitol in reducing ICP that had been increased by a cerebral lesion and a space-occupying mass; the underlying mechanisms responsible for the reduction might differ. Because of the powerful hemodynamic properties of the saline/dextran in circulatory shock, administration of the solution in patients with multiple traumas and head injury might be particularly advantageous for the prevention of secondary ischemic brain damage.
Similar articles
-
7.2% NaCl/10% dextran 60 versus 20% mannitol for treatment of intracranial hypertension.Acta Neurochir Suppl (Wien). 1994;60:494-8. doi: 10.1007/978-3-7091-9334-1_135. Acta Neurochir Suppl (Wien). 1994. PMID: 7526628
-
[Hypertonic solutions and intracranial pressure].Schweiz Med Wochenschr. 1996 Sep 28;126(39):1635-43. Schweiz Med Wochenschr. 1996. PMID: 8927967 Review. French.
-
Head injury and hemorrhagic shock: studies of the blood brain barrier and intracranial pressure after resuscitation with normal saline solution, 3% saline solution, and dextran-40.Surgery. 1988 Apr;103(4):398-407. Surgery. 1988. PMID: 2451302
-
Hypertonic fluid resuscitation from subarachnoid hemorrhage in rats: a comparison between small volume resuscitation and mannitol.J Neurol Sci. 2006 Feb 15;241(1-2):73-82. doi: 10.1016/j.jns.2005.10.016. Epub 2005 Dec 15. J Neurol Sci. 2006. PMID: 16343544
-
Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension.Crit Care Med. 2000 Sep;28(9):3301-13. doi: 10.1097/00003246-200009000-00032. Crit Care Med. 2000. PMID: 11008996 Review.
Cited by
-
Osmotherapy for elevated intracranial pressure: a critical reappraisal.Clin Pharmacokinet. 2000 Jan;38(1):23-40. doi: 10.2165/00003088-200038010-00002. Clin Pharmacokinet. 2000. PMID: 10668857 Review.
-
A 28-days sub-acute toxicity study in swiss albino mice to evaluate toxicity profile of neurotol plus (mannitol and glycerol combination).Int J Biomed Sci. 2009 Dec;5(4):428-33. Int J Biomed Sci. 2009. PMID: 23675168 Free PMC article.
-
Osmotic therapy: fact and fiction.Neurocrit Care. 2004;1(2):219-33. doi: 10.1385/NCC:1:2:219. Neurocrit Care. 2004. PMID: 16174920 Review.
-
Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients - a randomized clinical trial [ISRCTN62699180].Crit Care. 2005 Oct 5;9(5):R530-40. doi: 10.1186/cc3767. Epub 2005 Aug 9. Crit Care. 2005. PMID: 16277715 Free PMC article. Clinical Trial.
-
Hyperosmolar therapy for intracranial hypertension.Neurocrit Care. 2012 Aug;17(1):117-30. doi: 10.1007/s12028-011-9649-x. Neurocrit Care. 2012. PMID: 22090171 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources